Cargando…

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

Sarcoidosis is a chronic multisystem disease of unknown etiology, characterized by noncaseating granulomatous infiltration of virtually any organ system. Treatment is often undertaken in an attempt to resolve symptoms or prevent progression to organ failure. Previous studies have suggested a promine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callejas-Rubio, José Luis, López-Pérez, Lourdes, Ortego-Centeno, Norberto
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643111/ https://www.ncbi.nlm.nih.gov/pubmed/19337437

Ejemplares similares

Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis
por: Sánchez-Cano, Daniel, et al.
Publicado: (2013)

Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

One world, one health: The novel coronavirus COVID-19 epidemic()
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

Simultaneous Improvement of Cutaneous Sarcoidosis and Psoriasis Vulgaris on Administration of a Tumor Necrosis Factor Alpha Inhibitor
por: Kim, Young Shin, et al.
Publicado: (2023)

Mesenteric Inflammatory Venoocclusive Disease in a Patient with Sjögren's Syndrome
por: Rios-Fernández, Raquel, et al.
Publicado: (2014)

Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study
por: Ortego-Jurado, Miguel, et al.
Publicado: (2015)

Altered AKT1 and MAPK1 Gene Expression on Peripheral Blood Mononuclear Cells and Correlation with T-Helper-Transcription Factors in Systemic Lupus Erythematosus Patients
por: Garcia-Rodriguez, Sonia, et al.
Publicado: (2012)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

COVID-19 vaccine literacy in patients with systemic autoimmune diseases
por: Correa-Rodríguez, María, et al.
Publicado: (2022)

Clinical course of Covid-19 in a cohort of patients with Behçet disease
por: Correa-Rodríguez, María, et al.
Publicado: (2022)

Clinical course of Covid-19 in a cohort of patients with Behçet disease
por: Correa-Rodríguez, María, et al.
Publicado: (2022)

A Case of Sarcoidosis Associated With Anti–Tumor Necrosis Factor Treatment
por: Baha, Ayse, et al.
Publicado: (2015)

Virus y vasculitis sistémicas
por: Cervantes Bonet, B., et al.
Publicado: (2006)

Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
por: Ikediobi, Ogechi, et al.
Publicado: (2015)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
por: Banse, Christopher, et al.
Publicado: (2013)

Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection()
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
por: Reitblat, Tatiana, et al.
Publicado: (2013)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature
por: Park, Su-Kyung, et al.
Publicado: (2017)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
por: Correa-Rodríguez, María, et al.
Publicado: (2019)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus
por: Yen, Chung-Yang, et al.
Publicado: (2022)

Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
por: Panse, Ketaki, et al.
Publicado: (2023)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Systemic use of tumor necrosis factor alpha as an anticancer agent
por: Roberts, Nicholas J., et al.
Publicado: (2011)

Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
por: Masukawa, Ena, et al.
Publicado: (2021)

The Utility of Frequent Laboratory Monitoring for Patients on Tumor Necrosis Factor-Alpha Inhibitors in Dermatology
por: Houpe, Jessica E., et al.
Publicado: (2022)

Dietary Intake of Free Sugars is Associated with Disease Activity and Dyslipidemia in Systemic Lupus Erythematosus Patients
por: Correa-Rodríguez, María, et al.
Publicado: (2020)

Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
por: Jahnich, Nina, et al.
Publicado: (2023)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
por: Agarwal, Renu, et al.
Publicado: (2012)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report
por: Pan, Xiaoli, et al.
Publicado: (2021)

Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
por: Nair, Shaalina, et al.
Publicado: (2022)

Giant cell arteritis: is the clinical spectrum of the disease changing?
por: González-Gay, Miguel Á., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hkq5ruas32tovmdgq65j7ubgle